OUR BOLD MOVES

Transform our go-to-market model

We are partnering with others to address the patient affordability challenge by exploring new, flexible payment approaches, including value-based agreements, and being bold in how we expand access to our medicines.
placeholder
Transform our go-to-market model

Identifying Innovative Partnerships That Benefit AFib Patients
placeholder
Transform our go-to-market model

Improving Chemotherapy Access in Nigeria
placeholder
Transform our go-to-market model

Biosimilars as a Catalyst With the Potential to Drive Real Value in Health Care
placeholder
Transform our go-to-market model

More At-Risk Children in Developing Countries Are Protected From Pneumococcal Disease
placeholder
Transform our go-to-market model

Reaching Patients in Need Around the World With Critical Cancer Care Treatments
placeholder
Transform our go-to-market model

Expanding Access to Overdose-Reversing Naloxone in Health Clinics Across the U.S.
placeholder
Transform our go-to-market model

A Home of Hope for Breast Cancer Patients
It’s easy to say that everything we do is driven by our purpose, but our 2019 milestones – everything from regulatory approvals of breakthrough therapies to announcements surrounding our current R&D programs – show the multitude of ways we are helping patients. While we continue to navigate the issues that dominate the environment today, we’ll do so with a singular goal to help patients.

Joan Campion

Vice President, Chief Communications Officer
Transform our go-to-market model
placeholder
Transform our go-to-market model

Harnessing Drone Technology for Timely Delivery of Critical Medicines and Vaccines
placeholder
Transform our go-to-market model

New Hospital Business Delivers Vital Medicines Where They Are Needed Most
placeholder
Transform our go-to-market model

Providing Assistance to Underserved Patient Populations and Addressing Health Disparities
placeholder
Transform our go-to-market model

Increasing Use of Real-World Data to Help Improve Cancer Care
placeholder
Transform our go-to-market model

One Step Closer to a Trachoma-Free World
placeholder
Transform our go-to-market model

Sourcing Local Innovation to Help Combat Infectious Diseases in Low- and Middle-Income Countries
placeholder
Transform our go-to-market model

Combining Upjohn and Mylan to Create a New Champion for Global Health
placeholder
Transform our go-to-market model

Collaborating to Raise Awareness of ATTR-CM
Explore our bold moves

Unleash the power of our people

Explore our bold moves

Deliver first-in-class science

Explore our bold moves

Transform our go-to-market model

Explore our bold moves

Win the digital race in pharma

Explore our bold moves

Lead the conversation

Unleash the power of our people
Deliver first-in-class science
Transform our go-to-market model
Win the digital race in pharma
Lead the conversation